AGIO

27.6004.03%
BM

Brian M. Goff

CEO & Director

Mr. Brian M. Goff, M.B.A., is Independent Director of Intellia Therapeutics, Inc. since June 2024. He has been Chief Executive Officer and Director at Agios Pharmaceuticals, Inc. since August 08, 2022. He had been Executive Vice President at Alexion Pharmaceuticals, Inc. since June 01, 2017 and had been its Chief Commercial and Global Operations Officer since October 2019. Mr. Goff leads the global commercial and operations teams, which includes responsibility for country operations in each of Alexion’s affiliates in North America, EMEA, Japan, Asia Pacific and Latin America. Mr. Goff is a proven global biopharmaceutical executive with a track record of consistently delivering sustainable growth through multiple business cycles. He has deep expertise in commercial operations across multiple therapeutic areas, as well as broad expertise managing global cross-functional teams, including R&D, Medical Affairs, Manufacturing and Quality with a number of industry-leading biopharmaceutical companies. He served as the Chief Operating Officer at Neurovance, Inc. from December 14, 2016 to March 2017. Mr. Goff served as an Executive Vice President and President of Hematology at Baxalta Incorporated from January 2015 to July 2016. Mr. Goff served as an Executive Officer of the Primary Care Business Unit at Novartis AG. He served as Vice President and Head of Primary Care Marketing at Novartis AG. From June 2012 to December 2014, he served with Baxter Healthcare Corporation as Global Hemophilia Franchise Head. Prior to joining Baxter in 2012, Mr. Goff served as Vice President and Head of Novartis Pharmaceuticals’ multi-billion-dollar Primary Care business. Previously at Novartis’ Swiss headquarters, he led the global marketing of their flagship cardiovascular brand and spent 14 years in a variety of commercial leadership positions at Johnson & Johnson, including 10 years in CNS disorders. He held several positions at NPC from 2007 to April 2010, serving as Vice President and Head of Primary Care Marketing and Customer Innovation Strategy. Prior to joining NPC, he served as Global Director for two of Novartis' key products. He joined Novartis in March 2005 following a 14-year career in sales and marketing at the pharmaceutical division of Johnson & Johnson. He served as a Director at Neurovance, Inc. from December 14, 2016 to March 2017. He served as a Director of Idenix Pharmaceuticals Inc. from March 2012 to May 15, 2012. He is a Member of the General Medicines Executive Committee at NPC. Mr. Goff holds a Bachelor of Arts in Economics from Skidmore College and an M.B.A. from the Wharton School of the University of Pennsylvania.

Positions